2 cme credits

granted by the SSMO and SSH

Management of Multiple Myeloma Patients During the COVID-19 Pandemic

Length: 120 minutes

It should take approximately 2 hours to complete this module.

Purpose:

This module will combine two sections: a webinar-based section, which will include an expert panel discussion and a text-based section that will provide a comprehensive overview of the latest knowledge, experience, and available information regarding the risks and management of multiple myeloma patients during the COVID-19 outbreak as well as multiple myeloma patients infected with SARS-CoV-2.

This module will:

  • Present the latest clinical experiences and case reports from renowned experts on COVID-19 and multiple myeloma in a webinar-based panel discussion
  • Provide essential up-to-date data on the epidemiology, pathophysiology, and potential treatments for COVID-19
  • Introduce the prevalence of COVID-19 among patients with multiple myeloma and discuss the risks for unfavorable outcomes
  • Discuss available recommendations and guidelines for the management of multiple myeloma patients during the COVID-19 pandemic
Begin Module